XML 51 R33.htm IDEA: XBRL DOCUMENT
v3.21.2

Restatement of Previously Issued Financial Statements (Tables) | 5 Months Ended
--- | ---
Dec. 31, 2020
Condensed Financial Information Disclosure [Abstract] |
Schedule of effects of restatements on previously issued financial statements |
|  | As Previously Reported |  | Adjustments |  | As Restated
Balance sheet as of October 19, 2020 (audited) |  |  |  |  |  |  |  |  |  |  |  |
Warrant liabilities |  | $ | — |  |  | $ | 5,157,000 |  |  | $ | 5,157,000 |
Class A common stock subject to possible redemption |  |  | 107,104,620 |  |  |  | (5,157,000 | ) |  |  | 101,947,620 |
Class A common stock |  |  | 79 |  |  |  | 52 |  |  |  | 131 |
Additional paid-in capital |  |  | 5,004,204 |  |  |  | 191,060 |  |  |  | 5,195,264 |
Accumulated deficit |  |  | (4,608 | ) |  |  | (191,112 | ) |  |  | (195,720 | )
Balance sheet as of December 31, 2020 (audited) |  |  |  |  |  |  |  |  |  |  |  |
Warrant liabilities |  | $ | — |  |  | $ | 9,040,670 |  |  | $ | 9,040,670 |
Class A common stock subject to possible redemption |  |  | 106,882,750 |  |  |  | (9,040,670 | ) |  |  | 97,842,080 |
Class A common stock |  |  | 81 |  |  |  | 91 |  |  |  | 172 |
Additional paid-in capital |  |  | 5,148,390 |  |  |  | 4,074,691 |  |  |  | 9,223,081 |
Accumulated deficit |  |  | (148,751 | ) |  |  | (4,074,782 | ) |  |  | (4,223,533 | )
Statement of Operations for the period from August 11, 2020 (inception) to December 31, 2020 (audited) |  |  |  |  |  |  |  |  |  |  |  |
Change in fair value of warrant liabilities |  | $ | — |  |  | $ | 3,883,670 |  |  | $ | 3,883,670 |
Offering expense associated with warrant liabilities |  |  | — |  |  |  | 191,112 |  |  |  | 191,112 |
Net loss |  |  | (148,751 | ) |  |  | (4,074,782 | ) |  |  | (4,223,533 | )
Basic and diluted net loss per share, Class B common stock |  |  | (0.06 | ) |  |  | (1.42 | ) |  |  | (1.48 | )
Statement of Cash Flows for the period from August 11, 2020 (inception) to December 31, 2020 (audited) |  |  |  |  |  |  |  |  |  |  |  |
Net loss |  | $ | (148,751 | ) |  | $ | (4,074,782 | ) |  | $ | (4,223,533 | )
Offering costs allocable to warrant liabilities |  |  | — |  |  |  | 191,112 |  |  |  | 191,112 |
Change in fair value of warrant liabilities |  |  | — |  |  |  | 3,883,670 |  |  |  | 3,883,670 |
Initial classification of Class A common shares subject to possible redemption |  |  | 107,104,620 |  |  |  | (5,157,000 | ) |  |  | 101,947,620 |
Change in value of Class A common shares subject to possible redemption |  |  | (221,870 | ) |  |  | (3,883,670 | ) |  |  | (4,105,540 | )
Balance sheet as of October 19, 2020 (audited) |  | As Previously Restated and Reported in Form 10-K/A Amendment No. 1 |  | Adjustments |  | As Restated
Total assets |  | $ | 116,390,976 |  |  |  | — |  |  | $ | 116,390,976 |
Total liabilities |  | $ | 9,443,350 |  |  |  | — |  |  | $ | 9,443,350 |
Class A common stock subject to possible redemption |  |  | 101,947,620 |  |  |  | 13,052,380 |  |  |  | 115,000,000 |
Preferred stock |  |  | — |  |  |  | — |  |  |  | — |
Class A common stock |  |  | 131 |  |  |  | (131 | ) |  |  | — |
Class B common stock |  |  | 331 |  |  |  | — |  |  |  | 331 |
Additional paid-in capital |  |  | 5,195,264 |  |  |  | (5,195,264 | ) |  |  | — |
Accumulated deficit |  |  | (195,720 | ) |  |  | (7,856,985 | ) |  |  | (8,052,705 | )
Total stockholders’ equity (deficit) |  | $ | 5,000,006 |  |  | $ | (13,052,380 | ) |  | $ | (8,052,374 | )
Total Liabilities, Class A Common Stock Subject to Possible Redemption and Stockholders’ Equity (Deficit) |  | $ | 116,390,976 |  |  | $ | — |  |  | $ | 116,390,976 |
Balance sheet as of December 31, 2020 (audited) |  | As Previously Restated and Reported in Form 10-K/A Amendment No. 1 |  | Adjustments |  | As Restated
Total assets |  | $ | 116,067,608 |  |  |  | — |  |  | $ | 116,067,608 |
Total liabilities |  | $ | 13,225,520 |  |  |  | — |  |  | $ | 13,225,520 |
Class A common stock subject to possible redemption |  |  | 97,842,080 |  |  |  | 17,157,920 |  |  |  | 115,000,000 |
Preferred stock |  |  | — |  |  |  | — |  |  |  | — |
Class A common stock |  |  | 172 |  |  |  | (172 | ) |  |  | — |
Class B common stock |  |  | 288 |  |  |  | — |  |  |  | 288 |
Additional paid-in capital |  |  | 9,223,081 |  |  |  | (9,223,081 | ) |  |  | — |
Accumulated deficit |  |  | (4,223,533 | ) |  |  | (7,934,667 | ) |  |  | (12,158,200 | )
Total stockholders’ equity (deficit) |  | $ | 5,000,008 |  |  | $ | (17,157,920 | ) |  | $ | (12,157,912 | )
Total Liabilities, Class A Common Stock Subject to Possible Redemption and Stockholders’ Equity (Deficit) |  | $ | 116,067,608 |  |  | $ | — |  |  | $ | 116,067,608 |
For the Period From August 11, 2020 (Inception) Through December 31, 2020 |  | As Previously Restated and Reported in Form 10-K/A Amendment No. 1 |  | Adjustments |  | As Restated
Supplemental Disclosure of Noncash Financing Activities: |  |  |  |  |  |  |  |  |  |  |
Initial value of Class A common stock subject to possible redemption |  | $ | 101,947,620 |  |  | $ | (101,947,620 | ) |  | $ | —
Change in value of Class A common stock subject to possible redemption |  | $ | (4,105,540 | ) |  | $ | 4,105,540 |  |  | $ | —
|  | Net Loss Per Share
For the Period From August 11, 2020 (Inception) Through December 31, 2020 |  | As Previously Restated and Reported in Form 10-K/A Amendment No. 1 |  | Adjustments |  | As Restated
Net loss |  | $ | (4,223,533 | ) |  | $ | — |  |  | $ | (4,223,533 | )
Weighted average shares outstanding – Class A common stock |  |  | 11,500,000 |  |  |  | (5,588,028 | ) |  |  | 5,911,972 |
Basic and diluted net loss per share – Class A common stock |  | $ | 0.00 |  |  | $ | (0.48 | ) |  | $ | (0.48 | )
Weighted average shares outstanding – Class B common stock |  |  | 2,875,000 |  |  |  | — |  |  |  | 2,875,000 |
Basic and diluted net loss per share – Class B common stock |  | $ | (1.48 | ) |  | $ | 1.00 |  |  | $ | (0.48 | )

X
- References No definition available. + Details
Name: | srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract
Namespace Prefix: | srt_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of condensed financial statements, including, but not limited to, the balance sheet, income statement, and statement of cash flows. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 3 -Paragraph i -Subsection 10 + Details
Name: | srt_ScheduleOfCondensedFinancialStatementsTableTextBlock
Namespace Prefix: | srt_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration